Latest filing published 23 Aug 2021 for ClearPoint Neuro, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter G. Piferi: trading record in brief
All filings by Peter G. Piferi on record concern ClearPoint Neuro, Inc., in the capacity of senior executive. In total, 15 filings cover trades dated from 29 January 2016 to 20 August 2021.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 23 August 2021 came the latest disclosure, a share grant in ClearPoint Neuro, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter G. Piferi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,203 shares0Common StockSEC:0001420506-21-001338:0
- 8,929 shares@ US$3.4739.0% of flowCommon StockSEC:0001420506-21-001333:0
- 1,454 shares@ US$17.7032.3% of flowCommon StockSEC:0001420506-21-001322:0
- 3,141 shares@ US$3.2412.8% of flowCommon StockSEC:0001420506-21-000944:0
- 686 shares@ US$18.5415.9% of flowCommon StockSEC:0001420506-21-000867:0
5 of 5 declarations
